Clinical TrialsSearch results
Number of results: 318
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)
- Acute promyelocytic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2007-03-19
Other
- Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study
- acute promyelocytic leukemia
- Japan Adult Leukemia Study Group (JALSG)
- 2005-09-13
Other
- Multicenter study of a randomized controlled trial with or without maintenance/intensification therapy in patients with previously untreated acute promyelocytic leukemia (JALSG APL97 study)
- acute promyelocytic leukemia (APL)
- Japan Adult Leukemia Study Group
- 2005-09-14
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17
Other
- Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung Cancer
- Advanced Non-small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-14
Other
- Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancer
- Advanced colorectal cancer
- Showa University School of Medicin
- 2009-02-28
Other
- A phase II study of CBDCA and TS-1 in patients with advanced non-small cell lung cancer
- Advanced non-small cell lung cancer
- Gunma University Hospital
- 2009-03-03
Other
- A phase II study of gemcitabine and TS-1 in erderly patients with advanced non-small cell lung cancer
- Advanced non-small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- Randomized Phase III Trial Comparing Gefitinib with Carboplatin/Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- NEJ Gefitinib Study Group
- 2008-12-31